Konruns(603590.SH)

Last Updated 00:00:00
longbridge loading

Konruns released its performance for the first three quarters, with a net profit attributable to the parent company of 128 million yuan, a year-on-year increase of 13.19%

Zhitong·
SH
603590
+2.41%
Zhitong·
SH
603590
+2.41%

Konruns: Plans to repurchase company shares for 50 million to 100 million yuan

Zhitong·
SH
603590
+2.41%
Zhitong·
SH
603590
+2.41%

A-share innovative drug concept stocks fluctuated lower, with BETTA PHARMACEUTICALS falling over 10%, Jincheng Pharm, Konruns, Baillie Tianheng, Olymvax Biopharmaceuticals, and CCHT all dropping more than 5%

Zhitong·
SZ
300233
-1.95%
SZ
000661
+0.92%
SZ
300558
-0.57%
Zhitong·
SZ
300233
-1.95%
SZ
000661
+0.92%
SZ
300558
-0.57%

Konruns: KC1036 combined with PD-1 antibody and platinum-based chemotherapy has been approved for clinical trials as a first-line treatment for advanced recurrent or metastatic esophageal squamous cell carcinoma

Zhitong·
SH
603590
+2.41%
Zhitong·
SH
603590
+2.41%

Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declines

Zhitong·
SH
688166
-0.67%
SZ
301096
-1.64%
SH
688658
+2.37%
Zhitong·
SH
688166
-0.67%
SZ
301096
-1.64%
SH
688658
+2.37%

Innovative drug concept stocks fluctuate and rise, DEZHAN HEALTHCARE hits the limit up

Zhitong·
SH
603127
-1.89%
HK
06127
-3.75%
SZ
002262
+0.83%
Zhitong·
SH
603127
-1.89%
HK
06127
-3.75%
SZ
002262
+0.83%

Konruns: KC1036 included in the Drug Review Center's "Starlight Program" pilot project

Zhitong·
SH
603590
+2.41%
Zhitong·
SH
603590
+2.41%

Konruns' controlling shareholder plans to reduce holdings by no more than 3%

Zhitong·
SH
603590
+2.41%
Zhitong·
SH
603590
+2.41%

Konruns: There is no significant information that should be disclosed but has not been disclosed

Zhitong·
SH
603590
+2.41%
Zhitong·
SH
603590
+2.41%

The concept of innovative drugs has risen again, with Chemexpress up over 15%

Zhitong·
SH
688131
-1.53%
SH
603590
+2.41%
SH
600521
+1.36%
Zhitong·
SH
688131
-1.53%
SH
603590
+2.41%
SH
600521
+1.36%
© 2026 Longbridge｜Disclaimer